{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:48:59Z","timestamp":1792010939425,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.sapharm.2026.09.004","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:11:26Z","timestamp":1790061086000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benchmarking drug-related problem instruments: A systematic review of measurement properties"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9865-359X","authenticated-orcid":false,"given":"Lucas Tenorio Carmo do Nascimento","family":"Bezerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francielly Lima da","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4454-9605","authenticated-orcid":false,"given":"Cec\u00edlia Gomes","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuellen Silva de","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinara Rejane Viana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genival Araujo","family":"dos Santos J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Dias","family":"de Oliveira Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-0600","authenticated-orcid":false,"given":"Sabrina Joany Felizardo","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/bcp.15104","article-title":"Clinical usefulness of prediction tools to identify adult hospitalized patients at risk of drug-related problems: a systematic review of clinical prediction models and risk assessment tools","volume":"88","author":"Deawjaroen","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.sapharm.2026.09.004_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/106002809002401114","article-title":"Drug-related problems: their structure and function","volume":"24","author":"Strand","year":"1990","journal-title":"DICP"},{"issue":"7","key":"10.1016\/j.sapharm.2026.09.004_bib3","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1111\/bcp.15286","article-title":"Number-dependent association of potentially inappropriate medications with clinical outcomes and expenditures among community-dwelling older adults: a population-based cohort study","volume":"88","author":"Su","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sapharm.2026.09.004_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.26910","article-title":"Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis","volume":"6","author":"Tian","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2026.09.004_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40545-021-00312-z","article-title":"Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis","volume":"14","author":"Adem","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.sapharm.2026.09.004_bib6","volume":"vol. 9","author":"Ayele","year":"2021"},{"issue":"5","key":"10.1016\/j.sapharm.2026.09.004_bib7","article-title":"Cost of adverse drug events related to potentially inappropriate medication use: a systematic review","volume":"62","author":"Schiavo","year":"2022","journal-title":"J Am Pharm Assoc JAPhA"},{"issue":"9","key":"10.1016\/j.sapharm.2026.09.004_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1060028018765159","article-title":"Cost of prescription drug-related morbidity and mortality","volume":"52","author":"Watanabe","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2026.09.004_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vhri.2021.05.003","article-title":"A systematic review of potentially inappropriate medications use and related costs among the elderly","volume":"25","author":"Malakouti","year":"2021","journal-title":"Value in Health Regional Issues"},{"issue":"9","key":"10.1016\/j.sapharm.2026.09.004_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062589","article-title":"Healthcare costs of adverse drug reactions and potentially inappropriate prescribing in older adults: a population-based study","volume":"12","author":"Robinson","year":"2022","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.sapharm.2025.01.009","article-title":"Content validation of drug problem-oriented clinical record","volume":"21","author":"Gonzaga de Andrade Santos","year":"2025","journal-title":"Res Soc Adm Pharm"},{"issue":"9582","key":"10.1016\/j.sapharm.2026.09.004_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/11632610-000000000-00000","article-title":"Inappropriate prescribing: criteria, detection and prevention","volume":"29","author":"O'Connor","year":"2012","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17410-w","article-title":"Detection tools for prediction and identification of adverse drug reactions in older patients: a systematic review and meta-analysis","volume":"12","author":"Atmaja","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.sapharm.2026.09.004_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/1413-81232015203.04332013","article-title":"Constru\u00e7\u00e3o de instrumentos de medida na \u00e1rea da sa\u00fade","volume":"20","author":"Coluci","year":"2015","journal-title":"Ci\u00eanc sa\u00fade coletiva"},{"issue":"11","key":"10.1016\/j.sapharm.2026.09.004_bib17","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s11136-024-03761-6","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0","volume":"33","author":"Mokkink","year":"2024","journal-title":"Qual Life Res"},{"key":"10.1016\/j.sapharm.2026.09.004_bib18","first-page":"5","volume":"48","year":"2007","journal-title":"Ars Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.sapharm.2026.09.004_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.archger.2013.12.006","article-title":"An inter-rater reliability study of the prescribing indicated medications quality indicators of the assessing care of vulnerable elders (ACOVE) 3 criteria as a potentially inappropriate prescribing tool","volume":"58","author":"San-Jos\u00e9","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"issue":"5\u20136","key":"10.1016\/j.sapharm.2026.09.004_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00508-011-0061-5","article-title":"Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list","volume":"124","author":"Mann","year":"2012","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults","volume":"60","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2026.09.004_bib36","first-page":"79","article-title":"Expert consensus on a list of inappropriate prescribing after prescription review in pediatric units in Abidjan, C\u00f4te d'ivoire","volume":"10","author":"Doffou","year":"2021","journal-title":"Integrated Pharm Res Pract"},{"issue":"8","key":"10.1016\/j.sapharm.2026.09.004_bib37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","article-title":"Potentially inappropriate medications in the elderly: a French consensus panel list","volume":"63","author":"Laroche","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12877-021-02024-0","article-title":"Development of an explicit tool assessing potentially inappropriate medication use in Hong Kong elder patients","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.sapharm.2026.09.004_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.vhri.2017.10.002","article-title":"Ingredientes Farmac\u00e9uticos Activos Potencialmente Inapropiados en Adultos Mayores: lista IFAsPIAM: panel de Consenso Argentino","volume":"17","author":"Marzi","year":"2018","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.sapharm.2026.09.004_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-023-00630-4","article-title":"Development of a Malaysian potentially inappropriate prescribing screening tool in older adults (MALPIP): a Delphi study","volume":"16","author":"Chang","year":"2023","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.ajkd.2011.04.020","article-title":"Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD","volume":"58","author":"Desrochers","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sapharm.2026.09.004_bib27","first-page":"400","article-title":"Pharmacotherapy assessment in chronic kidney disease: validation of the PAIR instrument for use in Brazil","volume":"42","author":"Marquito","year":"2020","journal-title":"BJN"},{"key":"10.1016\/j.sapharm.2026.09.004_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.453","article-title":"Development and validation of PART (Pharmacotherapy Assessment in Renal Transplant Patients) criteria to assess drug-related problems in an outpatient renal transplant population: a cross-sectional study","volume":"7","author":"El Raichani","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11096-025-01977-1","article-title":"Updating the potentially inappropriate medication (PIM)-China criteria for 2024: a Delphi consensus study for improved medication safety in older adults","volume":"48","author":"Xing","year":"2026","journal-title":"Int J Clin Pharm"},{"issue":"7","key":"10.1016\/j.sapharm.2026.09.004_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016070","article-title":"PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients","volume":"7","author":"Desnoyer","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.sapharm.2026.09.004_bib44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.sapharm.2020.07.021","article-title":"Development of a list of potentially inappropriate medications for patients with heart failure (PIMHF)","volume":"17","author":"Jenghua","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2026.09.004_bib45","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jgo.2021.06.003","article-title":"Development of criteria for identifying potentially inappropriate prescribing in older adults with cancer receiving palliative care (PIP-CPC)","volume":"12","author":"Cadogan","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.sapharm.2026.09.004_bib46","article-title":"A tool for screening potentially inappropriate prescribing in Chinese children","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101171","article-title":"POPI (Pediatrics: omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify inappropriate prescribing","volume":"9","author":"Prot-Labarthe","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2026.09.004_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s11096-019-00819-1","article-title":"Interrater reliability of a tool to assess omission of prescription and inappropriate prescriptions in paediatrics","volume":"41","author":"Berthe-Aucejo","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2026.09.004_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.arcped.2016.02.010","article-title":"Validation par consensus d\u2019un outil d\u2019identification de prescriptions inappropri\u00e9es en p\u00e9diatrie (POPI)","volume":"23","author":"Prot-Labarthe","year":"2016","journal-title":"Arch Pediatr"},{"issue":"31\u201332","key":"10.1016\/j.sapharm.2026.09.004_bib47","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"10.1016\/j.sapharm.2026.09.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105143","article-title":"Medication appropriateness for older nursing home patients with a limited life expectancy: from STOPP\/START version 2 to the ReNeWAL criteria","volume":"25","author":"Dijk","year":"2024","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF03404338","article-title":"STOPP-START: adaptation en langue fran\u00e7aise d\u2019un outil de d\u00e9tection de la prescription m\u00e9dicamenteuse inappropri\u00e9e chez la personne \u00e2g\u00e9e","volume":"100","author":"Lang","year":"2009","journal-title":"Can J Public Health"},{"issue":"2","key":"10.1016\/j.sapharm.2026.09.004_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"issue":"11","key":"10.1016\/j.sapharm.2026.09.004_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijerph19116896","article-title":"Inappropriate prescriptions in older people\u2014translation and adaptation to Portuguese of the STOPP\/START screening tool","volume":"19","author":"Monteiro","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"issue":"2","key":"10.1016\/j.sapharm.2026.09.004_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afaf014","article-title":"Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria","volume":"54","author":"McGettigan","year":"2025","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib51","first-page":"600","article-title":"STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan","year":"2017","journal-title":"Age Ageing"},{"issue":"8","key":"10.1016\/j.sapharm.2026.09.004_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00228-014-1699-5","article-title":"Content validation of a tool for assessing risks for drug-related problems to be used by practical nurses caring for home-dwelling clients aged \u226565 years: a Delphi survey","volume":"70","author":"Dimitrow","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11096-019-00957-6","article-title":"Evaluation of a method for drug-related problems identification and classification in hospital setting: applicability and reliability","volume":"42","author":"Modesto","year":"2020","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2026.09.004_bib40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/106002809703100503","article-title":"Reliability of a modified medication appropriateness index in ambulatory older persons","volume":"31","author":"Fitzgerald","year":"1997","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11096-006-9048-0","article-title":"Validation of a comprehensive classification tool for treatment-related problems","volume":"28","author":"AbuRuz","year":"2006","journal-title":"Pharm World Sci"},{"issue":"2","key":"10.1016\/j.sapharm.2026.09.004_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7324\/JAPS.2020.102014","article-title":"Development and validation of the Vi-Med\u00ae tool for medication review","volume":"10","author":"Vo","year":"2020","journal-title":"J Appl Pharmaceut Sci"},{"key":"10.1016\/j.sapharm.2026.09.004_bib31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s13104-015-1566-1","article-title":"Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners","volume":"8","author":"Mast","year":"2015","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.sapharm.2026.09.004_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00228-021-03145-6","article-title":"REview of potentially inappropriate MEDIcation pr[e]scribing in seniors (REMEDI[e]S): french implicit and explicit criteria","volume":"77","author":"Roux","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40266-021-00862-6","article-title":"Ghent older people's prescriptions community pharmacy screening (GheOP3S)-Tool version 2: update of a tool to detect drug-related problems in older people in primary care","volume":"38","author":"Foubert","year":"2021","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.sapharm.2026.09.004_bib29","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1093\/pubmed\/fdv090","article-title":"Older patients' prescriptions screening in the community pharmacy: development of the ghent older People's prescriptions community pharmacy screening (GheOP3S) tool","volume":"38","author":"Tommelein","year":"2016","journal-title":"J Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-013-1575-8","article-title":"Inappropriate prescribing: a systematic overview of published assessment tools","volume":"70","author":"Kaufmann","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sapharm.2026.09.004_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081934","article-title":"Pharmacist-led primary care interventions to promote medicines optimisation and reduce overprescribing: a systematic review of UK studies and initiatives","volume":"14","author":"Chambers","year":"2024","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clinthera.2020.02.005","article-title":"Drug-related problems in home-dwelling older adults: a systematic review","volume":"42","author":"Pl\u00e1cido","year":"2020","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib58","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3233\/JAD-240575","article-title":"Prevalence of potentially inappropriate medications in older adults with cognitive impairment or dementia attending memory clinics: a systematic review and meta-analysis","volume":"101","author":"Sharma","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.sapharm.2026.09.004_bib59","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1111\/jgs.19035","article-title":"Clinical impact of medication review and deprescribing in older inpatients: a systematic review and meta-analysis","volume":"72","author":"Carollo","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2026.09.004_bib60","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12877-024-05297-3","article-title":"Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis","volume":"24","author":"Inglis","year":"2024","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.sapharm.2026.09.004_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2024.2305770","article-title":"Impact of pharmaceutical care interventions in improving clinical outcomes among patients with pulmonary tuberculosis: a systematic review","volume":"17","author":"Awad","year":"2024","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101450","article-title":"Impact of pharmaceutical care interventions on multidisciplinary care of older patients with cancer: a systematic review","volume":"14","author":"Herledan","year":"2023","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"10.1016\/j.sapharm.2026.09.004_bib63","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.sapharm.2020.07.016","article-title":"Economic impact of clinical pharmaceutical activities in hospital wards: a systematic review","volume":"17","author":"Baudouin","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2026.09.004_bib64","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jcpt.13408","article-title":"Clinical and economic impacts of explicit tools detecting prescribing errors: a systematic review","volume":"46","author":"Farhat","year":"2021","journal-title":"J Clin Pharm Therapeut"},{"issue":"5","key":"10.1016\/j.sapharm.2026.09.004_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ijpp.12649","article-title":"The outcome of domiciliary medication reviews and their impact: a systematic review","volume":"28","author":"McCormick","year":"2020","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2026.09.004_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11096-024-01834-7","article-title":"Identification, classification, and documentation of drug related problems in community pharmacy practice in Europe: a scoping review","volume":"47","author":"Hochhold","year":"2025","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2026.09.004_bib67","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13690-024-01295-4","article-title":"The epidemiology of drug-related hospital admissions in paediatrics \u2013 a systematic review","volume":"82","author":"Eberl","year":"2024","journal-title":"Arch Public Health"},{"issue":"6","key":"10.1016\/j.sapharm.2026.09.004_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jcpt.13606","article-title":"Systematic review of the prevalence and nature of drug-related problems in paediatric patients","volume":"47","author":"Mi","year":"2022","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.sapharm.2026.09.004_bib69","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12887-019-1875-y","article-title":"Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review","volume":"19","author":"Sutherland","year":"2019","journal-title":"BMC Pediatr"},{"issue":"10","key":"10.1016\/j.sapharm.2026.09.004_bib70","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s40264-021-01099-3","article-title":"Drug-Related problems in hospitalised patients with chronic kidney disease: a systematic review","volume":"44","author":"Alruqayb","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.sapharm.2026.09.004_bib71","doi-asserted-by":"crossref","unstructured":"Venugopal J, S S, A R, Karnan D. Drug-related problems in cancer patients: a systematic review. J Oncol Pharm Pract. Published online April 9, 2024. doi:10.1177\/10781552241229662.","DOI":"10.1177\/10781552241229662"},{"key":"10.1016\/j.sapharm.2026.09.004_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-86293-4","article-title":"Drug related problems and associated factors among thyroid disorder patients in Northwest Ethiopia","volume":"15","author":"Dagnew","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.sapharm.2026.09.004_bib73","article-title":"Drug-related problems in hospitalized patients with type 2 diabetes mellitus: a systematic review","volume":"12","author":"Awang Jihadi","year":"2023","journal-title":"Explor Res Clin Soc Pharm"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:21:34Z","timestamp":1792009294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126001944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"alternative-id":["S1551741126001944"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.09.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benchmarking drug-related problem instruments: A systematic review of measurement properties","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}